Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Background: Ganoderma lucidum (Lingzhi; LZ) and San-Miao-San (SMS) are Chinese medicines (CMs) used to treat inflammatory ailments and numbing syndrome/arthralgia syndrome (Bi Zheng), respectively. Given that the main symptoms of systemic lupus erythematosus (SLE) include inflammation of the joints, joint pain, edema and palpitations of the heart because of problems associated with Bi Zheng, it was envisaged that LZ and SMS could be used as potential treatments for this autoimmune disease. This study aims to investigate the anti-inflammatory activity of a combination formulation containing LZ and SMS (LZ-SMS) in SLE mice.
著者Cai Z, Wong CK, Dong J, Jiao D, Chu M, Leung PC, Lau CBS, Lau CP, Tam LS, Lam CWK
期刊名稱Chinese Medicine
詳細描述doi: 10.1186/s13020-016-0093-x. eCollection 2016.
出版年份2016
月份4
日期29
卷號11
出版社BIOMED CENTRAL LTD
國際標準期刊號1749-8546
語言英式英語
Web of Science 學科類別Integrative & Complementary Medicine; Pharmacology & Pharmacy

上次更新時間 2020-24-10 於 03:04